Carcinoma breast stage IV

Search with Google Search with Bing
Information
Disease name
Carcinoma breast stage IV
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02755272 Active, not recruiting Phase 2 A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer May 31, 2016 May 2026
NCT00433095 Completed Phase 2 Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer
NCT00669565 Completed Phase 2 Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer July 2008 August 2010
NCT00199212 Completed Phase 1 PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 October 2003 December 2007
NCT01631552 Completed Phase 1/Phase 2 Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer December 17, 2012 August 13, 2020
NCT03511781 Completed N/A Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer September 2015 March 2021
NCT06281860 Recruiting Phase 1 Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration November 24, 2023 February 1, 2026
NCT02183805 Terminated Phase 2 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer June 17, 2014 December 15, 2020
NCT01531764 Terminated Phase 2 BIBW 2992 (Afatinib) and Vinorelbine July 2012 September 2013
NCT02161315 Unknown status Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer April 2014 December 2016
NCT02140437 Withdrawn Phase 2 Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC March 2014 June 2016
NCT01906112 Withdrawn Phase 3 Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. August 2013 August 2019